He nui nā hoʻoweliweli maʻi hanu i ka hoʻoilo
Ua kūleʻa nō hoʻi nā hana e hōʻemi ai i ka laha ʻana o SARS-CoV-2 i ka hōʻemi ʻana i ka laha ʻana o nā maʻi hanu ʻē aʻe. I ka hōʻemi ʻana o nā ʻāina he nui i ka hoʻohana ʻana i ia mau hana, e kaʻahele pū ʻo SARS-CoV-2 me nā maʻi hanu ʻē aʻe, e hoʻonui ana i ka hiki ke loaʻa nā maʻi like.
Ua wānana nā loea he ahulau maʻi ʻekolu paha i kēia hoʻoilo ma muli o ka hui pū ʻana o nā piko kau o ka maʻi influenza (Flu) a me ka maʻi respiratory syndrome (RSV) me ka maʻi ahulau SARS-CoV-2. ʻOi aku ka nui o nā hihia o ka Flu a me RSV i kēia makahiki ma mua o ka manawa like i nā makahiki i hala. Ua hoʻonui hou nā ʻano hou o BA.4 a me BA.5 o ka maʻi SARS-CoV-2 i ka maʻi ahulau.
Ma ka "World Flu Day 2022 Symposium" ma Nowemapa 1, 2022, ua kālailai piha ʻo Zhong Nanshan, he loea o ka Chinese Academy of Engineering, i ke kūlana o ka maʻi palū ma ka home a ma waho, a ua hana i ka noiʻi a me ka hoʻoholo hou loa i ke kūlana o kēia manawa."Ke kū nei ke ao nei i ka pilikia o nā maʻi ahulau i hoʻohui ʻia e ka maʻi ahulau SARS-CoV-2 a me ka maʻi ahulau influenza." i ʻōlelo ai ʻo ia, "ʻOi aku hoʻi i kēia hoʻoilo, pono nō e hoʻoikaika i ka noiʻi ʻana i nā pilikia ʻepekema o ka pale ʻana a me ka kaohi ʻana i ka influenza."Wahi a nā helu helu o ka US CDC, ua piʻi nui ka nui o nā kipa ʻana i nā haukapila no nā maʻi hanu ma ʻAmelika Hui Pū ʻIa ma muli o ka hui pū ʻana o ka maʻi palū a me nā maʻi puʻuwai hou.
ʻO ka piʻi ʻana o nā ʻike ʻana o ka RSV a me nā kipa ʻana i nā keʻena pilikia e pili ana i ka RSV a me nā hoʻokipa ʻana i nā haukapila ma nā ʻāpana he nui o ʻAmelika Hui Pū ʻIa, me kekahi mau ʻāpana e kokoke ana i nā pae kiʻekiʻe o ke kau. I kēia manawa, ua hōʻea ka nui o nā hihia maʻi RSV ma ʻAmelika Hui Pū ʻIa i ka piko kiʻekiʻe loa i loko o 25 mau makahiki, e hoʻopiha ana i nā haukapila o nā keiki, a ua pani ʻia kekahi mau kula.
Ua puka mai ka maʻi ahulau ma Australia i ʻApelila o kēia makahiki a ua mau no kahi o 4 mau mahina. Ma ka lā 25 o Kepakemapa, aia he 224,565 mau hihia i hōʻoia ʻia e ka hale hana o ka maʻi ahulau, a ua hopena i 305 mau make e pili ana. I ka hoʻohālikelike ʻana, ma lalo o nā hana pale ʻana i ka maʻi ahulau SARS-CoV-2, e loaʻa ana ma kahi o 21,000 mau hihia maʻi ahulau ma Australia i ka makahiki 2020 a emi ma mua o 1,000 i ka makahiki 2021.
Ua hōʻike ka hōʻike hebedoma 35 o ke Kikowaena Maʻi Flu Kina i ka makahiki 2022 ua ʻoi aku ka nui o nā hihia maʻi influenza ma nā panalāʻau ʻākau ma mua o ka pae o ka manawa like ma 2019-2021 no 4 mau pule i ka lālani, a e ʻoi aku ka koʻikoʻi o ke kūlana e hiki mai ana. I ka waena o Iune, ua piʻi ka nui o nā hihia like me ka maʻi influenza i hōʻike ʻia ma Guangzhou ma 10.38 mau manawa i hoʻohālikelike ʻia me ka makahiki i hala.
Ua hōʻike ʻia nā hopena o kahi noiʻi hoʻohālike 11-ʻāina i hoʻokuʻu ʻia e The Lancet Global Health i ʻOkakopa ua piʻi ka maʻalahi o ka heluna kanaka o kēia manawa i ka maʻi influenza a hiki i ka 60% i hoʻohālikelike ʻia me ka wā ma mua o ke ahulau. Ua wānana pū ʻia e piʻi ka nui o ka manawa o ka maʻi flu 2022 i 1-5 mau manawa, a e piʻi ka nui o ke ahulau a hiki i 1-4 mau manawa.
212,466 mau mākua me ka maʻi SARS-CoV-2 i hoʻokomo ʻia i ka haukapila. Ua hoʻopaʻa ʻia nā hoʻāʻo no nā maʻi hui pū ʻana o ka maʻi hanu no 6,965 mau maʻi me SARS-CoV-2. Ua ʻike ʻia ka maʻi hui pū ʻana o ka maʻi i loko o 583 (8·4%) mau maʻi: 227 mau maʻi i loaʻa i nā maʻi influenza, 220 mau maʻi i loaʻa i ka maʻi respiratory syncytial, a he 136 mau maʻi i loaʻa i nā adenovirus.
Ua pili ka maʻi like ʻana me nā maʻi influenza me ka piʻi ʻana o ka loaʻa ʻana o ka ea mechanical invasive i hoʻohālikelike ʻia me ka maʻi SARS-CoV-2 mono-infection. Ua pili nui nā maʻi SARS-CoV-2 me nā maʻi influenza a me nā adenovirus me ka piʻi ʻana o ka make. ʻO ka OR no ka ea mechanical invasive i ka maʻi influenza co-infection he 4.14 (95% CI 2.00-8.49, p=0.0001). ʻO ka OR no ka make ma ka haukapila i nā maʻi i loaʻa i ka maʻi influenza he 2.35 (95% CI 1.07-5.12, p=0.031). ʻO ka OR no ka make ma ka haukapila i nā maʻi i loaʻa i ka maʻi adenovirus he 1.6 (95% CI 1.03-2.44, p=0.033).
Hōʻike akāka nā hopena o kēia noiʻi iā mākou he kūlana weliweli loa ka maʻi like ʻana me ka maʻi SARS-CoV-2 a me ka maʻi influenza.
Ma mua o ka hoʻomaka ʻana o ka SARS-CoV-2, ua like loa nā hōʻailona o nā maʻi hanu like ʻole, akā ua ʻokoʻa nā ʻano lapaʻau. Inā ʻaʻole hilinaʻi nā mea maʻi i nā hoʻokolohua he nui, e paʻakikī hou aku ka mālama ʻana i nā maʻi hanu, a e hoʻonele maʻalahi ia i nā kumuwaiwai haukapila i nā kau hanana kiʻekiʻe. No laila, he kuleana koʻikoʻi nā hoʻokolohua hui he nui i ka hōʻailona lapaʻau, a hiki i nā kauka ke hāʻawi i ka hōʻailona ʻokoʻa o nā pathogens i nā mea maʻi me nā hōʻailona hanu ma o kahi hāpana swab hoʻokahi.
Hoʻāʻo Macro & Micro-Test SARS-CoV-2 Hoʻonā ʻike hui lehulehu hanu
Loaʻa iā Macro & Micro-Test nā kahua loea e like me ka fluorescent quantitative PCR, isothermal amplification, immunization, a me ka molecular POCT, a hāʻawi i nā ʻano huahana ʻike hui hanu SARS-CoV-2. Ua loaʻa i nā huahana āpau ka palapala hōʻoia EU CE, me ka hana huahana maikaʻi loa a me ka ʻike mea hoʻohana maikaʻi.
1. Pahu RT-PCR fluorescent manawa maoli no ka ʻike ʻana i ʻeono ʻano pathogens hanu
Mana KūlokoE nānā pono i ke kaʻina hana hoʻokolohua e hōʻoia i ka maikaʻi o nā hoʻokolohua.
Ka Hana KiʻekiʻeʻIke ka Multiplex real-time PCR i nā pahuhopu like ʻole no SARS-CoV-2, Flu A, Flu B, Adenovirus, Mycoplasma pneumoniae, a me ka Respiratory syncytial virus.
ʻIke kiʻekiʻe300 Kope/mL no SARS-CoV-2, 500 Kope/mL no ka maʻi influenza A, 500 Kope/mL no ka maʻi influenza B, 500 Kope/mL no ka maʻi respiratory syncytial, 500 Kope/mL no ka mycoplasma pneumoniae, a me 500 Kope/mL no ka adenovirus.
2. Pahu ʻike hui pū ʻia ʻo SARS-CoV-2/Influenza A/Influenza B Nucleic Acid (Fluorescence PCR)
Mana KūlokoE nānā pono i ke kaʻina hana hoʻokolohua e hōʻoia i ka maikaʻi o nā hoʻokolohua.
Ka Hana KiʻekiʻeʻIke ka Multiplex real-time PCR i nā pahuhopu like ʻole no SARS-CoV-2, Flu A a me Flu B.
ʻIke kiʻekiʻe300 Kope/mL o SARS-CoV-2,500 Kope/mL o lFV A a me 500 Kope/mL o lFV B.
3. Pahu ʻike antigen SARS-CoV-2, Influenza A a me Influenza B (Immunochromatography)
Maʻalahi e hoʻohana
Mahana o ka lumi Ka lawe ʻana a me ka mālama ʻana ma 4-30°℃
ʻIke kiʻekiʻe a me ke kikoʻī
| Inoa Huahana | Nā kikoʻī |
| ʻO ka pahu RT-PCR fluorescent manawa maoli no ka ʻike ʻana i ʻeono ʻano pathogens hanu | 20 mau hoʻāʻo/kit,48 mau hoʻāʻo/kit,50 mau hoʻāʻo/kit |
| Pahu ʻIke ʻAkika Nukleika SARS-CoV-2/Influenza A/Influenza B (Fluorescence PCR) | 48 mau hoʻāʻo/kit,50 mau hoʻāʻo/kit |
| Pahu ʻike antigen SARS-CoV-2, Influenza A a me Influenza B (Immunochromatography) | 1 hoʻāʻo/pahu,20 mau hoʻāʻo/kit |
Ka manawa hoʻouna: Dec-09-2022